San Diego-based Samumed, a small-molecule drug platform, has secured $438 million in funding. The investors were not named.
Source: Press Release
We have just sent you an email so you can verify your account. Please check your spam or junk folder just in case it's been delivered there.If you do not receive this within five minutes, please try and sign in again. If the problem persists, please email: email@example.com.
Copyright PEI Media
Not for publication, email or dissemination